Synonyms: | 5-Heptenamide,7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-butenyl]-5-oxocyclopentyl]-N-(methylsulfonyl)-,(5Z)- (9CI); 5-Heptenamide,7-[3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl]-N-(methylsulfonyl)-,[1R-[1a(Z),2b(1E,3R*),3a]]-; CP 34089; Nalador; SHB 286; Sulprostone; ZK 57671 |
InChI: | InChI=1S/C23H31NO7S/c1-32(29,30)24-23(28)12-8-3-2-7-11-19-20(22(27)15-21(19)26)14-13-17(25)16-31-18-9-5-4-6-10-18/h2,4-7,9-10,13-14,17,19-20,22,25,27H,3,8,11-12,15-16H2,1H3,(H,24,28)/b7-2-,14-13+/t17-,19-,20-,22-/m1/s1 |
Specification: |
? Sulprostone?with cas registry number of 60325-46-4?is a light brown solid, known as (Z)-7-((1R,2R,3R)-3-Hydroxy-2-((E)-(3R)-(3-hydroxy-4-phenoxy-1-butenyl))-5-oxocyclopentyl)-N-(methylsulfonyl)-5-heptenamide ;?16-Phenoxy-17,18,19,20 tetranor prostaglandin E(sub 2) methyl sulfonylamide?; 16-Phenoxy-omega-17,18,19,20-tetranor pge-2 methylsulfonylamide ; 16-Phenoxy-omega-17,18,19,20-tetranor prostaglandin E2 methylsulfonylamide ; 5-Heptenamide, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-N-(methylsulfonyl)-, (1R-(1a(Z),2b(1E,3R*),3a))- ; 5-Heptenamide, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-N-(methylsulfonyl)-, (1R-(1alpha(Z),2beta(1E,3R*),3alpha))- ; CP 34089 ; CP-34,089 ; Nalador ; SHB 286 ; Sulprostona ; Sulprostona [INN-Spanish] ; Sulprostonum ; Sulprostonum [INN-Latin] ; Sulprostone [USAN:INN]?; UNII-501Q5EQ1GM ; ZK 57 671 ; ZK 57671 .?It is incompatible with?strong oxidizing agents. When heated to decomposition, it yields?Carbon monoxide , Carbon dioxide , Nitrogen oxides. Sulprostone is an oxytocic, an analogue of prostaglandin E2.
|